These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1611840)

  • 1. Minimal models and the labelled IVGTT.
    Godsland IF; Walton C
    Diabet Med; 1992 Jun; 9(5):489-91. PubMed ID: 1611840
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimal models of glucose disappearance: lessons from the labelled IVGTT.
    Caumo A; Giacca A; Morgese M; Pozza G; Micossi P; Cobelli C
    Diabet Med; 1991 Nov; 8(9):822-32. PubMed ID: 1837509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of glucose kinetics following an oral glucose load. Methods and applications.
    Proietto J
    Horm Metab Res Suppl; 1990; 24():25-30. PubMed ID: 2272623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotope dilution studies of the effect of insulin and diabetes on glucose transfer rates.
    Csorba TR
    Horm Metab Res; 1969 May; 1(3):97-107. PubMed ID: 4947792
    [No Abstract]   [Full Text] [Related]  

  • 5. Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment.
    Ward GM; Walters JM; Barton J; Alford FP; Boston RC
    Metabolism; 2001 May; 50(5):512-9. PubMed ID: 11319711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to measure insulin action in vivo.
    Scheen AJ; Paquot N; Castillo MJ; Lefèbvre PJ
    Diabetes Metab Rev; 1994 Jul; 10(2):151-88. PubMed ID: 7956677
    [No Abstract]   [Full Text] [Related]  

  • 7. Bayesian two-compartment and classic single-compartment minimal models: comparison on insulin modified IVGTT and effect of experiment reduction.
    Callegari T; Caumo A; Cobelli C
    IEEE Trans Biomed Eng; 2003 Dec; 50(12):1301-9. PubMed ID: 14656059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose effectiveness is the major determinant of intravenous glucose tolerance in the rat.
    McArthur MD; You D; Klapstein K; Finegood DT
    Am J Physiol; 1999 Apr; 276(4):E739-46. PubMed ID: 10198311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity.
    Vicini P; Caumo A; Cobelli C
    Am J Physiol; 1997 Nov; 273(5):E1024-32. PubMed ID: 9374690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models.
    Regittnig W; Trajanoski Z; Leis HJ; Ellmerer M; Wutte A; Sendlhofer G; Schaupp L; Brunner GA; Wach P; Pieber TR
    Diabetes; 1999 May; 48(5):1070-81. PubMed ID: 10331412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model.
    Caumo A; Cobelli C
    Am J Physiol; 1993 May; 264(5 Pt 1):E829-41. PubMed ID: 8498505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTT.
    Krudys KM; Dodds MG; Nissen SM; Vicini P
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1038-46. PubMed ID: 15632105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glucose effectiveness in the determination of glucose tolerance.
    Best JD; Kahn SE; Ader M; Watanabe RM; Ni TC; Bergman RN
    Diabetes Care; 1996 Sep; 19(9):1018-30. PubMed ID: 8875104
    [No Abstract]   [Full Text] [Related]  

  • 14. CIGMA as a tool in the study of NIDDM.
    Turner RC; Rudenski AS; Hosker JP; Matthews DR; Levy JC; O'Rahilly SP
    Prog Clin Biol Res; 1988; 265():13-26. PubMed ID: 3405996
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance.
    Berrish TS; Hetherington CS; Alberti KG; Walker M
    Diabetologia; 1995 Jun; 38(6):699-704. PubMed ID: 7672492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects.
    Avogaro A; Vicini P; Valerio A; Caumo A; Cobelli C
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E532-40. PubMed ID: 8638702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodological issues in the application of the minimal model: effects of glucose dose, basal glucose concentration, test duration and modelling constraint.
    Godsland IF; Luzio S; Wynn V; Owens DR
    Diabetes Res; 1994; 26(4):139-53. PubMed ID: 7648789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose metabolism in children with renal failure: oral or intravenous glucose tolerance.
    Amendt P; Filler G
    Exp Clin Endocrinol Diabetes; 2000; 108(4):253-8. PubMed ID: 10961355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constant infusion and bolus injection of stable-label tracer give reproducible and comparable fasting HGO.
    Hovorka R; Eckland DJ; Halliday D; Lettis S; Robinson CE; Bannister P; Young MA; Bye A
    Am J Physiol; 1997 Jul; 273(1 Pt 1):E192-201. PubMed ID: 9252496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of insulin sensitivity and glucose effectiveness during a standardized breakfast test: comparison with the minimal model analysis of an intravenous glucose tolerance test.
    Aloulou I; Brun JF; Mercier J
    Metabolism; 2006 May; 55(5):676-90. PubMed ID: 16631446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.